Annual CFI
-$14.00 K
-$38.16 M-100.04%
30 June 2022
Summary:
Applied Genetic Technologies annual cash flow from investing activities is currently -$14.00 thousand, with the most recent change of -$38.16 million (-100.04%) on 30 June 2022. During the last 3 years, it has fallen by -$38.16 million (-100.04%).AGTC Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFI
-$304.00 K
+$556.00 K+64.65%
30 September 2022
Summary:
Applied Genetic Technologies quarterly cash flow from investing activities is currently -$304.00 thousand, with the most recent change of +$556.00 thousand (+64.65%) on 30 September 2022.AGTC Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFI
-$1.70 M
-$1.69 M-12064.29%
30 September 2022
Summary:
Applied Genetic Technologies TTM cash flow from investing activities is currently -$1.70 million, with the most recent change of -$1.69 million (-12064.29%) on 30 September 2022.AGTC TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AGTC Cash From Investing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | -100.0% | -122.0% | -105.1% |
| 5 y5 years | -100.1% | -215.2% | -107.0% |
AGTC Cash From Investing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -100.0% | -100.9% | -102.6% |
Applied Genetic Technologies Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$304.00 K(-64.7%) | -$1.70 M(>+9900.0%) |
| June 2022 | -$14.00 K(-100.0%) | -$860.00 K(+325.7%) | -$14.00 K(-100.1%) |
| Mar 2022 | - | -$202.00 K(-40.1%) | $19.84 M(-38.3%) |
| Dec 2021 | - | -$337.00 K(-124.3%) | $32.17 M(-3.4%) |
| Sept 2021 | - | $1.39 M(-92.7%) | $33.29 M(-12.7%) |
| June 2021 | $38.15 M(+354.2%) | $18.99 M(+56.5%) | $38.15 M(+1112.6%) |
| Mar 2021 | - | $12.13 M(+1449.3%) | $3.15 M(-37.4%) |
| Dec 2020 | - | $783.00 K(-87.5%) | $5.03 M(-65.0%) |
| Sept 2020 | - | $6.24 M(-139.0%) | $14.38 M(+71.2%) |
| June 2020 | $8.40 M(-55.9%) | -$16.01 M(-214.3%) | $8.40 M(-77.2%) |
| Mar 2020 | - | $14.01 M(+38.2%) | $36.91 M(+34.3%) |
| Dec 2019 | - | $10.14 M(+3739.4%) | $27.48 M(+12.9%) |
| Sept 2019 | - | $264.00 K(-97.9%) | $24.34 M(+27.9%) |
| June 2019 | $19.03 M(-42.4%) | $12.50 M(+173.2%) | $19.03 M(-692.6%) |
| Mar 2019 | - | $4.58 M(-34.6%) | -$3.21 M(-86.2%) |
| Dec 2018 | - | $7.00 M(-238.6%) | -$23.19 M(-1900.6%) |
| Sept 2018 | - | -$5.05 M(-48.1%) | $1.29 M(-96.1%) |
| June 2018 | $33.02 M(+0.6%) | -$9.73 M(-36.8%) | $33.02 M(-31.1%) |
| Mar 2018 | - | -$15.40 M(-148.9%) | $47.95 M(-25.7%) |
| Dec 2017 | - | $31.48 M(+18.0%) | $64.57 M(+142.7%) |
| Sept 2017 | - | $26.68 M(+413.1%) | $26.60 M(-18.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2017 | $32.81 M(-132.5%) | $5.20 M(+327.2%) | $32.81 M(-28.6%) |
| Mar 2017 | - | $1.22 M(-118.7%) | $45.95 M(+76.3%) |
| Dec 2016 | - | -$6.49 M(-119.7%) | $26.07 M(-147.5%) |
| Sept 2016 | - | $32.89 M(+79.4%) | -$54.82 M(-45.6%) |
| June 2016 | -$100.80 M(-663.4%) | $18.34 M(-198.2%) | -$100.80 M(-14.6%) |
| Mar 2016 | - | -$18.66 M(-78.6%) | -$118.03 M(+25.3%) |
| Dec 2015 | - | -$87.38 M(+567.2%) | -$94.23 M(+1638.5%) |
| Sept 2015 | - | -$13.10 M(-1276.7%) | -$5.42 M(-130.3%) |
| June 2015 | $17.89 M(-135.2%) | $1.11 M(-78.3%) | $17.89 M(-157.1%) |
| Mar 2015 | - | $5.14 M(+259.7%) | -$31.34 M(-7.9%) |
| Dec 2014 | - | $1.43 M(-86.0%) | -$34.04 M(-18.0%) |
| Sept 2014 | - | $10.21 M(-121.2%) | -$41.53 M(-18.3%) |
| June 2014 | -$50.83 M(+251.0%) | -$48.12 M(-2073.1%) | -$50.83 M(+203.7%) |
| Mar 2014 | - | $2.44 M(-140.2%) | -$16.73 M(-13.3%) |
| Dec 2013 | - | -$6.06 M(-758.2%) | -$19.30 M(+43.2%) |
| Sept 2013 | - | $921.00 K(-106.6%) | -$13.48 M(-6.9%) |
| June 2013 | -$14.48 M(>+9900.0%) | -$14.03 M(>+9900.0%) | -$14.48 M(+3118.0%) |
| Mar 2013 | - | -$130.00 K(-44.9%) | -$450.00 K(+40.6%) |
| Dec 2012 | - | -$236.00 K(+181.0%) | -$320.00 K(+281.0%) |
| Sept 2012 | - | -$84.00 K | -$84.00 K |
| June 2012 | -$108.00 K | - | - |
FAQ
- What is Applied Genetic Technologies annual cash flow from investing activities?
- What is the all time high annual CFI for Applied Genetic Technologies?
- What is Applied Genetic Technologies quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Applied Genetic Technologies?
- What is Applied Genetic Technologies TTM cash flow from investing activities?
- What is the all time high TTM CFI for Applied Genetic Technologies?
What is Applied Genetic Technologies annual cash flow from investing activities?
The current annual CFI of AGTC is -$14.00 K
What is the all time high annual CFI for Applied Genetic Technologies?
Applied Genetic Technologies all-time high annual cash flow from investing activities is $38.15 M
What is Applied Genetic Technologies quarterly cash flow from investing activities?
The current quarterly CFI of AGTC is -$304.00 K
What is the all time high quarterly CFI for Applied Genetic Technologies?
Applied Genetic Technologies all-time high quarterly cash flow from investing activities is $32.89 M
What is Applied Genetic Technologies TTM cash flow from investing activities?
The current TTM CFI of AGTC is -$1.70 M
What is the all time high TTM CFI for Applied Genetic Technologies?
Applied Genetic Technologies all-time high TTM cash flow from investing activities is $64.57 M